M, B., S, U., P, K., BC, B., K, L., M, D., . . . D, N. (2013). Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. International journal of cancer, 133(10), 2341. https://doi.org/10.1002/ijc.28239
Chicago Style (17th ed.) CitationM, Bernasconi, et al. "Early Gene Expression Changes by Epstein-Barr Virus Infection of B-cells Indicate CDKs and Survivin as Therapeutic Targets for Post-transplant Lymphoproliferative Diseases." International Journal of Cancer 133, no. 10 (2013): 2341. https://doi.org/10.1002/ijc.28239.
MLA (9th ed.) CitationM, Bernasconi, et al. "Early Gene Expression Changes by Epstein-Barr Virus Infection of B-cells Indicate CDKs and Survivin as Therapeutic Targets for Post-transplant Lymphoproliferative Diseases." International Journal of Cancer, vol. 133, no. 10, 2013, p. 2341, https://doi.org/10.1002/ijc.28239.